Prolidase activity has been measured in tissues such as plasma, erythrocytes, leukocytes, and dermal fibroblasts (45, 46) in conditions including chronic liver disease (21), osteoporosis (47), osteoarthritis (48), DM (47), and uremia (49). Here, PEPD is linked to diabetes mellitus.